Texas Permanent School Fund acquired a new position in shares of Cantel Medical Corp. (NYSE:CMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 26,503 shares of the company’s stock, valued at approximately $2,065,000. Texas Permanent School Fund owned 0.06% of Cantel Medical Corp. as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Integrated Investment Consultants LLC acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $161,000. LS Investment Advisors LLC acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $172,000. First Quadrant L P CA acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $233,000. Cue Financial Group Inc. acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $234,000. Finally, Bank of Montreal Can acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $248,000. 83.88% of the stock is owned by institutional investors.
Cantel Medical Corp. (CMD) opened at 73.79 on Friday. The firm has a 50-day moving average of $75.90 and a 200 day moving average of $76.88. The company has a market capitalization of $3.06 billion, a price-to-earnings ratio of 43.66 and a beta of 1.23. Cantel Medical Corp. has a one year low of $68.19 and a one year high of $88.81.
Cantel Medical Corp. (NYSE:CMD) last announced its earnings results on Thursday, June 8th. The company reported $0.51 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.51. The business had revenue of $192.10 million during the quarter, compared to the consensus estimate of $193.84 million. Cantel Medical Corp. had a net margin of 9.50% and a return on equity of 17.75%. The firm’s quarterly revenue was up 10.6% compared to the same quarter last year. Equities research analysts predict that Cantel Medical Corp. will post $2.06 earnings per share for the current fiscal year.
The company also recently announced a semiannual dividend, which was paid on Monday, July 31st. Shareholders of record on Monday, July 17th were issued a $0.07 dividend. The ex-dividend date of this dividend was Thursday, July 13th. This represents a yield of 0.18%. Cantel Medical Corp.’s dividend payout ratio is presently 8.28%.
TRADEMARK VIOLATION WARNING: “26,503 Shares in Cantel Medical Corp. (NYSE:CMD) Acquired by Texas Permanent School Fund” was posted by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.com-unik.info/2017/08/12/26503-shares-in-cantel-medical-corp-nysecmd-acquired-by-texas-permanent-school-fund.html.
Several equities research analysts have weighed in on the stock. Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price target for the company in a research report on Wednesday, August 2nd. Zacks Investment Research raised shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, August 1st. Benchmark Co. cut shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a research report on Thursday, June 8th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $91.67.
In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 13,000 shares of the business’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $76.36, for a total value of $992,680.00. Following the completion of the transaction, the chairman now directly owns 3,124,222 shares in the company, valued at $238,565,591.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Charles M. Diker sold 35,000 shares of the business’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total transaction of $2,643,200.00. Following the completion of the transaction, the chairman now owns 3,114,520 shares of the company’s stock, valued at $235,208,550.40. The disclosure for this sale can be found here. Insiders own 14.90% of the company’s stock.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
What are top analysts saying about Cantel Medical Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cantel Medical Corp. and related companies.